TP53 and rectal cancer: The extensive genetic and epigenetic profiling of the primary rectal cancer and of the matched metastases demonstrated the absence of KRAS, NRAS, BRAF and PIK3CA mutations, a microsatellite stable phenotype; in addition, there were no TP53 alterations and no recurrent CNAs on chromosome 8.